Early day motion tabled by primary sponsor Paul Flynn (Labour), on Tuesday, 30 January 2007, in the House of Commons. It is signed by 15 members in total.
GLAXOSMITHKLINE AND SEROXAT
That this House challenges GlaxoSmithKline (GSK) to act on its vacuous threat to sue the BBC on its evidence that GSK had deliberately suppressed and distorted trial results of the anti-depressant Seroxat to conceal its direct links to suicide in teenagers; notes that GSK's own unpublished studies showed that the drug actually trebles the risk of suicidal thoughts and behaviour in depressed children without any proven benefit over placebos; urges the Medicine and Healthcare Products Regulatory Agency to accelerate its criminal investigation into GSK begun three years ago; and looks forward to an early prosecution of a company that no longer deserves public trust.
Secondary information
- Type
- Early day motion
- Reference
- 768
- Session
- 2006-07
- Other sponsors
- Alan Meale
- Andrew Dismore
- Andrew George
- Graham Stringer
- Alan Simpson
- Subjects
- Paroxetine GlaxoSmithKline
- Link
- View this Early day motion on www.parliament.uk
Librarians' tools
- Timestamp
- 2023-02-14 09:29:52 +0000
- URI
- http://data.parliament.uk/edms/32464
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/edms/32464
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/edms/32464